| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |